• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Cyprus·Healthcare·MDMG.L
Share

MD Medical Group Investments Plc Stocks

$ 0Last Updated 23.03.2026

Issuer Rating

4/7
Performance

Strong

Risk

High

Recommendation

Hold

Market Cap

$ 52.59M

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

MD Medical Group Investments Plc, an investment holding company, provides healthcare services for women and children in Russia. It offers a range of services in the areas of obstetrics and gynaecology, fertility and IVF treatment, and pediatrics, as well as diagnostics, urology, radiology, surgery, traumatology, rehabilitation, cardiology, oncology, endovascular, laboratory examinations, and other services. The company also retails pharmaceutics; and provides assistance services. As of March 28, 2022, it managed 47 healthcare facilities, including 8 hospitals and 39 out-patient clinics in 27 cities and 25 regions. The company was founded in 2006 and is based in Nicosia, Cyprus. MD Medical Group Investments Plc is a subsidiary of MD Medical Holding Limited.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.05.2026 16:01

Highlights in small-caps: Ebola vaccine, SpaceX IPO beneficiaries, newcomers to Russell

23.05.2026 13:01

Highlights of the week: SpaceX development plans, Nvidia reporting, new Nebius competitor

23.05.2026 03:19

Anthropic is preparing a new round of investment with a valuation higher than OpenAI - Bloomberg

23.05.2026 03:04

Billionaires including Musk and Zuckerberg convinced Trump to delay AI executive order - WP

23.05.2026 01:17

The Dow hit a record for the second day in a row. The S&P 500 has its best weekly streak since 2023

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026